vs
Side-by-side financial comparison of PagerDuty, Inc. (PD) and Xeris Biopharma Holdings, Inc. (XERS). Click either name above to swap in a different company.
PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $85.8M, roughly 1.5× Xeris Biopharma Holdings, Inc.). PagerDuty, Inc. runs the higher net margin — 129.7% vs 12.9%, a 116.8% gap on every dollar of revenue. On growth, Xeris Biopharma Holdings, Inc. posted the faster year-over-year revenue change (42.8% vs 4.7%). Over the past eight quarters, Xeris Biopharma Holdings, Inc.'s revenue compounded faster (45.3% CAGR vs 5.9%).
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
Xeris Biopharma Holdings, Inc. is a specialty biopharmaceutical company that develops and commercializes targeted therapies for rare endocrine, metabolic, and dermatological conditions. It operates across global markets, focusing on delivering accessible, easy-to-administer treatment options for underserved patient segments.
PD vs XERS — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $124.5M | $85.8M |
| Net Profit | $161.6M | $11.1M |
| Gross Margin | 85.3% | — |
| Operating Margin | 6.5% | 19.5% |
| Net Margin | 129.7% | 12.9% |
| Revenue YoY | 4.7% | 42.8% |
| Net Profit YoY | 2827.7% | 316.7% |
| EPS (diluted) | $1.69 | $0.07 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $124.5M | $85.8M | ||
| Q3 25 | $123.4M | $74.4M | ||
| Q2 25 | $119.8M | $71.5M | ||
| Q1 25 | $121.4M | $60.1M | ||
| Q4 24 | $118.9M | $60.1M | ||
| Q3 24 | $115.9M | $54.3M | ||
| Q2 24 | $111.2M | $48.1M | ||
| Q1 24 | $111.1M | $40.6M |
| Q4 25 | $161.6M | $11.1M | ||
| Q3 25 | $9.6M | $621.0K | ||
| Q2 25 | $-7.2M | $-1.9M | ||
| Q1 25 | $-8.8M | $-9.2M | ||
| Q4 24 | $-5.9M | $-5.1M | ||
| Q3 24 | $-10.9M | $-15.7M | ||
| Q2 24 | $-17.1M | $-15.0M | ||
| Q1 24 | $-28.2M | $-19.0M |
| Q4 25 | 85.3% | — | ||
| Q3 25 | 84.6% | — | ||
| Q2 25 | 84.0% | — | ||
| Q1 25 | 83.6% | — | ||
| Q4 24 | 83.0% | — | ||
| Q3 24 | 82.7% | — | ||
| Q2 24 | 82.6% | — | ||
| Q1 24 | 81.7% | — |
| Q4 25 | 6.5% | 19.5% | ||
| Q3 25 | 2.9% | 9.0% | ||
| Q2 25 | -8.6% | 6.3% | ||
| Q1 25 | -9.6% | -5.1% | ||
| Q4 24 | -8.7% | 2.8% | ||
| Q3 24 | -13.8% | -23.8% | ||
| Q2 24 | -19.5% | -17.0% | ||
| Q1 24 | -30.1% | -35.1% |
| Q4 25 | 129.7% | 12.9% | ||
| Q3 25 | 7.8% | 0.8% | ||
| Q2 25 | -6.0% | -2.7% | ||
| Q1 25 | -7.2% | -15.3% | ||
| Q4 24 | -5.0% | -8.5% | ||
| Q3 24 | -9.4% | -29.0% | ||
| Q2 24 | -15.4% | -31.2% | ||
| Q1 24 | -25.3% | -46.7% |
| Q4 25 | $1.69 | $0.07 | ||
| Q3 25 | $0.10 | $0.00 | ||
| Q2 25 | $-0.07 | $-0.01 | ||
| Q1 25 | $-0.12 | $-0.06 | ||
| Q4 24 | $-0.07 | $-0.02 | ||
| Q3 24 | $-0.14 | $-0.11 | ||
| Q2 24 | $-0.26 | $-0.10 | ||
| Q1 24 | $-0.34 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $547.8M | $111.0M |
| Total DebtLower is stronger | — | $220.3M |
| Stockholders' EquityBook value | $320.5M | $13.7M |
| Total Assets | $1.0B | $383.5M |
| Debt / EquityLower = less leverage | — | 16.10× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $547.8M | $111.0M | ||
| Q3 25 | $567.9M | $91.6M | ||
| Q2 25 | $597.1M | $59.3M | ||
| Q1 25 | $570.8M | $58.4M | ||
| Q4 24 | $542.2M | $71.6M | ||
| Q3 24 | $599.3M | $69.4M | ||
| Q2 24 | $592.8M | $77.6M | ||
| Q1 24 | $571.2M | $87.4M |
| Q4 25 | — | $220.3M | ||
| Q3 25 | — | $219.5M | ||
| Q2 25 | — | $218.6M | ||
| Q1 25 | $484.5M | $229.8M | ||
| Q4 24 | — | $232.1M | ||
| Q3 24 | — | $216.2M | ||
| Q2 24 | — | $230.5M | ||
| Q1 24 | $489.5M | $229.7M |
| Q4 25 | $320.5M | $13.7M | ||
| Q3 25 | $180.7M | $-861.0K | ||
| Q2 25 | $145.7M | $-19.3M | ||
| Q1 25 | $129.8M | $-35.1M | ||
| Q4 24 | $111.6M | $-29.6M | ||
| Q3 24 | $164.7M | $-28.3M | ||
| Q2 24 | $174.0M | $-19.3M | ||
| Q1 24 | $171.6M | $-9.2M |
| Q4 25 | $1.0B | $383.5M | ||
| Q3 25 | $891.5M | $370.2M | ||
| Q2 25 | $926.8M | $334.7M | ||
| Q1 25 | $927.3M | $315.5M | ||
| Q4 24 | $866.8M | $323.1M | ||
| Q3 24 | $916.0M | $321.1M | ||
| Q2 24 | $924.0M | $331.7M | ||
| Q1 24 | $925.3M | $336.6M |
| Q4 25 | — | 16.10× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 3.73× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 2.85× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $24.8M | $20.0M |
| Free Cash FlowOCF − Capex | $24.1M | — |
| FCF MarginFCF / Revenue | 19.3% | — |
| Capex IntensityCapex / Revenue | 0.6% | — |
| Cash ConversionOCF / Net Profit | 0.15× | 1.81× |
| TTM Free Cash FlowTrailing 4 quarters | $117.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $24.8M | $20.0M | ||
| Q3 25 | $34.0M | $18.4M | ||
| Q2 25 | $30.7M | $182.0K | ||
| Q1 25 | $31.4M | $-10.0M | ||
| Q4 24 | $22.1M | $2.0M | ||
| Q3 24 | $35.8M | $-8.3M | ||
| Q2 24 | $28.6M | $-10.3M | ||
| Q1 24 | $22.2M | $-20.3M |
| Q4 25 | $24.1M | — | ||
| Q3 25 | $33.1M | — | ||
| Q2 25 | $30.2M | — | ||
| Q1 25 | $30.3M | — | ||
| Q4 24 | $21.5M | — | ||
| Q3 24 | $35.1M | — | ||
| Q2 24 | $28.2M | — | ||
| Q1 24 | $21.2M | — |
| Q4 25 | 19.3% | — | ||
| Q3 25 | 26.8% | — | ||
| Q2 25 | 25.2% | — | ||
| Q1 25 | 24.9% | — | ||
| Q4 24 | 18.1% | — | ||
| Q3 24 | 30.3% | — | ||
| Q2 24 | 25.4% | — | ||
| Q1 24 | 19.1% | — |
| Q4 25 | 0.6% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.4% | — | ||
| Q1 25 | 0.9% | — | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.4% | — | ||
| Q1 24 | 0.9% | — |
| Q4 25 | 0.15× | 1.81× | ||
| Q3 25 | 3.55× | 29.68× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
XERS
| Products | $83.4M | 97% |
| Other | $2.4M | 3% |
